[1] Cai-Yun Fu, et al. Hemokinin-1(4-11)-induced analgesia selectively up-regulates δ-opioid receptor expression in mice. PLoS One DOI:
10.1371/journal.pone.0090446[2] Francesca Bellucci, et al. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol. 2002 Jan;135(1):266-74. DOI:
10.1038/sj.bjp.0704443[3] YIXIN ZHANG . Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors[J]. Peptides, 2016, 83: Pages 8-15. DOI:
10.1016/j.peptides.2016.07.004[4] HONGJIN SONG. Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor[J]. International Journal of Biochemistry & Cell Biology, 2012, 44 9: Pages 1410-1421. DOI:
10.1016/j.biocel.2012.04.014[5] LIYING DAI. Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.[J]. Journal of Pharmacology and Experimental Therapeutics, 2012, 340 1: 27-36. DOI:
10.1124/jpet.111.186155[6] CAI Y. FU . In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice[J]. Brain, Behavior, and Immunity, 2008, 22 6: Pages 850-860. DOI:
10.1016/j.bbi.2007.12.010[7] ZI-QING KONG . Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats[J]. European journal of pharmacology, 2008, 590 1: Pages 310-316. DOI:
10.1016/j.ejphar.2008.05.049